S&P 500   3,328.23 (-0.04%)
DOW   29,322.46 (-0.09%)
QQQ   223.62 (+0.11%)
AAPL   318.06 (-0.21%)
MSFT   167.51 (+0.25%)
GOOGL   1,484.71 (+0.35%)
AMZN   1,871.37 (+0.36%)
CGC   24.37 (-2.13%)
NVDA   249.06 (-0.09%)
BABA   221.86 (-2.45%)
MU   58.66 (+1.73%)
GE   11.74 (-0.59%)
TSLA   541.40 (+6.05%)
AMD   51.25 (+0.63%)
T   38.52 (+0.34%)
ACB   2.02 (-5.18%)
F   9.19 (+0.33%)
NFLX   336.22 (-1.02%)
DIS   143.99 (-0.24%)
S&P 500   3,328.23 (-0.04%)
DOW   29,322.46 (-0.09%)
QQQ   223.62 (+0.11%)
AAPL   318.06 (-0.21%)
MSFT   167.51 (+0.25%)
GOOGL   1,484.71 (+0.35%)
AMZN   1,871.37 (+0.36%)
CGC   24.37 (-2.13%)
NVDA   249.06 (-0.09%)
BABA   221.86 (-2.45%)
MU   58.66 (+1.73%)
GE   11.74 (-0.59%)
TSLA   541.40 (+6.05%)
AMD   51.25 (+0.63%)
T   38.52 (+0.34%)
ACB   2.02 (-5.18%)
F   9.19 (+0.33%)
NFLX   336.22 (-1.02%)
DIS   143.99 (-0.24%)
S&P 500   3,328.23 (-0.04%)
DOW   29,322.46 (-0.09%)
QQQ   223.62 (+0.11%)
AAPL   318.06 (-0.21%)
MSFT   167.51 (+0.25%)
GOOGL   1,484.71 (+0.35%)
AMZN   1,871.37 (+0.36%)
CGC   24.37 (-2.13%)
NVDA   249.06 (-0.09%)
BABA   221.86 (-2.45%)
MU   58.66 (+1.73%)
GE   11.74 (-0.59%)
TSLA   541.40 (+6.05%)
AMD   51.25 (+0.63%)
T   38.52 (+0.34%)
ACB   2.02 (-5.18%)
F   9.19 (+0.33%)
NFLX   336.22 (-1.02%)
DIS   143.99 (-0.24%)
S&P 500   3,328.23 (-0.04%)
DOW   29,322.46 (-0.09%)
QQQ   223.62 (+0.11%)
AAPL   318.06 (-0.21%)
MSFT   167.51 (+0.25%)
GOOGL   1,484.71 (+0.35%)
AMZN   1,871.37 (+0.36%)
CGC   24.37 (-2.13%)
NVDA   249.06 (-0.09%)
BABA   221.86 (-2.45%)
MU   58.66 (+1.73%)
GE   11.74 (-0.59%)
TSLA   541.40 (+6.05%)
AMD   51.25 (+0.63%)
T   38.52 (+0.34%)
ACB   2.02 (-5.18%)
F   9.19 (+0.33%)
NFLX   336.22 (-1.02%)
DIS   143.99 (-0.24%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

EPA:CA - Carrefour Stock Price, Forecast & News

€14.76
+0.01 (+0.07 %)
(As of 01/21/2020 01:00 PM ET)
Today's Range
€14.60
Now: €14.76
€14.84
50-Day Range
€14.62
MA: €14.99
€15.25
52-Week Range
€16.31
Now: €14.76
€23.68
Volume1.74 million shs
Average Volume3.45 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Carrefour SA operates stores in various formats and channels in France, Spain, Italy, Belgium, Poland, Romania, Brazil, Argentina, China, and Taiwan. The company operates hypermarkets, supermarkets, convenience stores, cash and carry stores, and hypercash stores; e-commerce sites and m-commerce channels; and service stations. Its stores offer fresh produce; local products; consumer goods; and non-food products, including small household goods, textiles, and home appliances. Read More…

Industry, Sector and Symbol

Industry Grocery Stores
Sub-IndustryN/A
SectorConsumer Defensive
CUSIPN/A
CIKN/A
Phone+33-1-41042600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive CA News and Ratings via Email

Sign-up to receive the latest news and ratings for CA and its competitors with MarketBeat's FREE daily newsletter.


Carrefour (EPA:CA) Frequently Asked Questions

What is Carrefour's stock symbol?

Carrefour trades on the EPA under the ticker symbol "CA."

What price target have analysts set for CA?

10 equities research analysts have issued 1 year price targets for Carrefour's stock. Their forecasts range from €15.00 to €22.50. On average, they expect Carrefour's share price to reach €17.63 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for Carrefour.

What is the consensus analysts' recommendation for Carrefour?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carrefour in the last year. There are currently 2 sell ratings, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carrefour.

Has Carrefour been receiving favorable news coverage?

News headlines about CA stock have been trending positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Carrefour earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Carrefour.

Who are some of Carrefour's key competitors?

What other stocks do shareholders of Carrefour own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carrefour investors own include CARREFOUR SA/S (CRRFY), Renault (RNO), Bayer (BAYN), Basf (BAS), Bayerische Motoren Werke (BMW), Daimler (DAI), Deutsche Bank (DBK), Advanced Micro Devices (AMD), SUEZ/ADR (SZEVY) and VIVENDI SA/ADR (VIVHY).

Who are Carrefour's key executives?

Carrefour's management team includes the folowing people:
  • Mr. Alexandre Bompard, Chairman & CEO (Age 46)
  • Mr. Pierre-Jean Jerome Sivignon, Advisor to The CEO (Age 61)
  • Mr. Matthieu Malige, Chief Financial Officer
  • Ms. Mathilde Rodie, Head of Financial Communication & Investor Relations (Age 44)
  • Dominique Benneteau-Wood, Exec. Director of Communication for the Group & France

What is Carrefour's stock price today?

One share of CA stock can currently be purchased for approximately €14.76.

What is Carrefour's official website?

The official website for Carrefour is http://www.carrefour.com/.

How can I contact Carrefour?

Carrefour's mailing address is 33 avenue Emile Zola, BOULOGNE-BILLANCOURT, 92100, France. The company can be reached via phone at +33-1-41042600.


MarketBeat Community Rating for Carrefour (EPA CA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  326 (Vote Outperform)
Underperform Votes:  374 (Vote Underperform)
Total Votes:  700
MarketBeat's community ratings are surveys of what our community members think about Carrefour and other stocks. Vote "Outperform" if you believe CA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Featured Article: volatile stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel